Targeted, Highly Sensitive, Non-Invasive Cardiac Transplant Rejection Monitoring

Targeted, Highly Sensitive, Non-Invasive Cardiac Transplant Rejection Monitoring

The investigator's primary goal is to quantitatively detect donor-specific DNA in plasma of organ transplant recipients. The investigator believe's that donor specific DNA can be isolated and quantified from transplant recipient serum. The investigator hypothesizes that the percent level of donor DNA circulating in recipient serum will reflect transplant rejection.

Trial Website: https://clinicaltrials.gov/show/NCT02109575

Are you Eligible? (Inclusion Criteria)

Inclusion Criteria:

  • Any patient who is "listed" to undergo or has in the past undergone heart transplantation.

Exclusion Criteria:

  • Any patient who is not currently listed to undergo heart transplantation and has not previously received a heart transplant, or who is unable or unwilling to provide documented informed consent for self or through a legally authorized representative.

Specialty Area(s)

Trial Location

NYP/Columbia
New York, NY 10032
United States